Pharmaceuticals, Biotechnology and Life Sciences
Due to an increase in the incidence of medical ailments, the marketstudied is expected to grow over the forecast period.
Second Launch@Shares Competition Announced in Collaboration withMTTC/MALSI Conference and MassBio’s MassCONNECT Program
The global food enzymes market is expected to grow at a CAGR of 7.5%from 2019 to reach $3,125.1 million by 2024 from $2,176.9 million in2019.
Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.
Vivimed Life Sciences recalls Losartan Potassium three doses tablets, USP due traces of N-Nitroso-N-methyl-4-aminobutyric acid
Nuvera launches ThePURE Report, the first independent, standardized, annual assessmentof healthcare provider (HCP) satisfaction with pharmaceutical companies’patient support services, including their industry rankings againstcompetition.
Transgene Combined General Meeting (ordinary and extraordinary sessions) ofTransgene’s shareholders will be held on May 22, 2019,
The European Commission (EC) has licensed Dupixent (dupilumab), developed by Regeneron and Sanofi, for older than 12 patients as an add-on maintenance treatment for severe asthma with type 2 inflammation.
GERMANY-based contract development and manufacturing organization (CDMO) Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line to meet increasing demand for its specialist oncolytic virus and viral vector manufacturing services.
Denali has reported net loss of $39.0 million in the first quarter 2019, compared with a net loss of $23.7 million same period last year.